US 10106616
Antagonist antibodies to human prolactin receptor (PRLR)
granted A61KA61K2039/505A61K31/537
Quick answer
US patent 10106616 (Antagonist antibodies to human prolactin receptor (PRLR)) held by REGENERON PHARMACEUTICALS, INC. expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Oct 23 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 16
- CPC classes
- A61K, A61K2039/505, A61K31/537, A61K47/68031, A61K47/68033